Precision Medicine Offers Belatacept Monotherapy

NCT02939365 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Because of inability to get FDA approval for

Conditions

Transplantation

Interventions

DRUG: Belatacept

Sponsor

University of California, San Francisco

Collaborators

[object Object]